Overexpression of coupling factor 6 causes cardiac dysfunction under high-salt diet in mice

Journal of Hypertension

Volumn 28, Issue 11, 2010, Pages 2243-2251

  Ashitate, Toshihiro ^a   Osanai, Tomohiro ^a   Tanaka, Makoto ^a   Magota, Koji ^b   Echizen, Takashi ^a   Izumiyama, Kei ^a   Yokoyama, Hiroaki ^a   Shibutani, Shuji ^a   Hanada, Kenji ^a   Tomita, Hirofumi ^a   Okumura, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

congestive heart failure; coupling factor 6; nicotinamide adenine dinucleotide phosphate oxidase; reactive oxygen species; salt; tyrosine kinase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATE; COMPLEMENTARY DNA; COUPLING FACTOR 6; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; PHOSPHOLAMBAN; PROTEIN KINASE P60; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; HEART FUNCTION; HIGH SODIUM INTAKE; HYPERTENSION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RNA ISOLATION; SALT LOADING; SARCOPLASMIC RETICULUM; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 77958464698     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833dfcbe     Document Type: Article

References (34)

1. Boyer PD. The binding change mechanism for ATP synthase: some probabilities and possibilities. Biochim Biophys Acta 1993; 1140:215-250.
2. Walker JE, Fearnley IM, Gay NJ, Gibson BW, Northrop FD, Powell SJ, et al. Primary structure and subunit stoichiometry of F1-ATPase from bovine mitochondria. J Mol Biol 1985; 184:677-701.
3. Kagawa Y, Racker E. Partial resolution of the enzyme catalyzing oxidative phosphorylation: correlation of morphology and function in submitochondrial particles. J Biol Chem 1966; 241:2475-2482.
4. Walker JE, Runswick MJ, Poulter L. ATP synthase from bovine mitochondria: characterization and sequence analysis of two membrane associated subunits and of their corresponding c-DNAs. J Mol Biol 1987; 197:89-100.
5. Collinson IR, van Raaij MJ, Runswick MJ, Fearnley IM, Skehel JM, Orriss GL, et al. ATP synthase from bovine heart mitochondria: in vitro assembly of a stalk complex in the presence of F1-ATPase and its absence. J Mol Biol 1994; 242:408-421.
6. Osanai T, Kamada T, Fujiwara N, Katoh T, Takahashi K, Kimura M, et al. A novel inhibitory effect on prostacyclin synthesis of coupling factor 6 extracted from the heart of spontaneous hypertensive rats. J Biol Chem 1998; 273:31778-31783.
7. Osanai T, Tanaka M, Kamada T, Nakano T, Takahashi K, Okada S, et al. Mitochondrial coupling factor 6 as a potent endogenous vasoconstrictor. J Clin Invest 2001; 108:1023-1030.
8. Osanai T, Magota K, Tanaka M, Shimada M, Murakami R, Sasaki S, et al. Intracellular signaling for vasoconstrictor coupling factor 6: novel function of b-subunit of ATP synthase as receptor. Hypertension 2005; 46:1140-1146.
9. Osanai T, Okada S, Sirato K, Nakano T, Saitoh M, Magota K, et al. Mitochondrial coupling factor 6 is present on the surface of human vascular endothelial cells and is released by shear stress. Circulation 2001; 104:3132-3136.
10. Sasaki S, Osanai T, Tomita H, Matsunaga T, Magota K, Okumura K. Tumor necrosis factor alpha as an endogenous stimulator for circulating coupling factor 6. Cardiovasc Res 2004; 62:578-586.
11. Tomita H, Osanai T, Toki T, Sasaki S, Maeda N, Murakami R, et al. Troglitazone and 15-deoxy-delta12,14-proataglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells. Cardiovasc Res 2005; 67:134-141.
12. Tanaka M,Osanai T, Murakami R, Sasaki S, Tomita H,Maeda N,et al. Effect of vasoconstrictor coupling factor 6 on gene expression profile in human vascular endothelial cells: enhanced release of asymmetric dimethylarginine. J Hypertens 2006; 24:489-497.
13. Lemmens K, Fransen P, Sys SU, Brutsaert DL, Keulenaer GWD. Neuregulin-1 induces a negative inotropic effect in cardiac muscle: role of nitric oxide synthase. Circulation 2004; 109:324-326.
14. Osanai T, Sasaki S, Kamada T, Fujiwara N, Nakano T, Tomita H, et al. Circulating coupling factor 6 in human hypertension: role of reactive oxygen species. J Hypertens 2003; 21:2323-2328.
15. Ding WH, Chu SY, Jiang HF, Cai DY, Pang YZ, Tang CS, et al. Plasma mitochondrial coupling factor 6 in patients with acute myocardial infarction. Hypertens Res 2004; 27:717-722.
16. Osanai T, Nakamura M, Sasaki S, Tomita H, Saitoh M, Osawa H, et al. Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease. Kidney Int 2003; 64:2291-2297.
17. Li XL, Xing QC, Gao YY, Dong B, Pang YZ, Jiang HF, et al. Plasma level of mitochondrial coupling factor 6 increases in patients with type 2 diabetes mellitus. Int J Cardiol 2007; 117:411-412.
18. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005; 115:500-508.
19. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18:655-673.
20. Abramov AY, Jacobson J, Wientjes F, Hothersall J, Canevari L, Duchen MR. Expression and modulation of an NADPH oxidase in mammalian astrocytes. J Neurosci 2005; 25:9176-9184.
21. Lenda DM, Sauls BA, Boegehold MA. Reactive oxygen species may contribute to reduced endothelium-dependent dilation in rats fed high salt. Am J Physiol Heart Circ Physiol 2000; 279:H7-H14.
22. Ashitate T, Osanai T, Tanaka M, Magota K, Echizen T, Tomita H, et al. Generation and characterization of coupling factor 6-overexpressing transgenic mice. Hirosaki Med J 2009; 60:18-26.
23. Osanai T, Tomita H, Kushibiki M, Yamada M, Tanaka M, Ashitate T, et al. Coupling factor 6 enhances Src-mediated responsiveness to angiotensin II in resistance arterioles and cells. Cardiovasc Res 2009; 81:780-787.
24. Li JM, Gall NP, Grieve DJ, Chen M, Shah AM. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 2002; 40:477-484.
25. Periasamy M, Huke S. SERCA pump level is a critical determinant of Ca2\+ homeostasis and cardiac contractility. J Mol Cell Cardiol 2001; 33:1053-1063.
26. Akiba S, Chiba M, Mukaida Y, Sato T. Involvement of reactive oxygen species and SP-1 in fibronectin production by oxidized LDL. Biochem Biophys Res Commun 2003; 310:491-497.
27. Brady M, Koban MU, Dellow KA, Yacoub M, Boheler KR, Fuller SJ. Sp1 and Sp3 transcription factors are required for trans-activation of the human SERCA2 promoter in cardiomyocytes. Cardiovasc Res 2003; 60:347-354.
28. Na T, Dai DZ, Tang XY, Dai Y. Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU86017. Naunyn Schmiedebergs Arch Pharmacol 2007; 375:39-49.
29. MacDonald MJ. Evidence of the malate aspartate shuttle in pancreatic islet. Arch Biochem Biophys 1982; 213:643-649.
30. Osanai T, Okumura K. Therapeutic challenge to adiposity of the heart. Cir Res 2007; 100:1106-1108.
31. Siwik DA, Pagano PJ, Colucci WS. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 2001; 280:C53-C60.
32. Kumagai A, Osanai T, Katoh C, Tanaka M, Tomita H, Morimoto T, et al. Coupling factor 6 downregulates platelet endothelial cell adhesion molecule-1 via c-Src activation and acts as a proatherogenic molecule. Atherosclerosis 2008; 200:45-50.
33. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501.
34. Chowdhury AK, Watkins T, Parinandi NL, Saatian B, Kleinberg ME, Usatyuk PV, et al. Src-mediated tyrosine phosphorylation of p47phox in hyperoxia-induced activation of NADPH oxidase and generation of reactive oxygen species in lung endothelial cells. J Biol Chem 2005; 280:20700-20711.